Header Logo

Connection

Richard Grant to HIV Infections

This is a "connection" page, showing publications Richard Grant has written about HIV Infections.
Connection Strength

0.177
  1. Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. AIDS Behav. 2018 Nov; 22(11):3540-3549.
    View in: PubMed
    Score: 0.100
  2. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002 May; 17(5):377-81.
    View in: PubMed
    Score: 0.032
  3. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001 Oct 15; 33(8):1417-23.
    View in: PubMed
    Score: 0.031
  4. Community health care workers in South Africa are at increased risk for tuberculosis. S Afr Med J. 2010 Mar 30; 100(4):224, 226.
    View in: PubMed
    Score: 0.014

© 2024 Kaiser Permanente